- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02239159
Acupuncture-assisted-anesthesia to Improve Postoperative Outcome After Digestive Surgery in Elderly Patients (AID)
July 6, 2017 updated by: Zhihong LU, Air Force Military Medical University, China
Acupuncture-assisted-anesthesia to Improve Complications After Digestive Surgery in Elderly Patients:Multi-center Double-blinded Randomized Controlled Trial
The investigators assume that transcutaneous electric acupoint stimulation (TEAS) pretreatment may activate the endogenous protective mechanism, as a result protect the patients against subsequent surgical stress pregnancy.
And TEAS may induce the production of endogenous analgesic transmitters, so develop an anesthetic-sparing effect.
The investigators believe this intervention will reduce the subsequent incidence, duration and severity of organ dysfunction, possibly reducing the morbidity, even mortality.
So in this study, the investigators hypothesize that TEAS before anesthesia and during surgery would decrease the morbidity and mortality of postoperative complications in 30 days after digestive surgery in elderly patients .
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Patients older than 65 years old are at higher risk of postoperative morbidity and mortality.
With the increasing number of old patients scheduled for digestive surgery, exploring methods to decrease postoperative morbidity is very important.
Noninvasive methods may be easier to clinically use.
Transcutaneous electric acupoint stimulation (TEAS)has been proved to decrease need for general anesthetics during anesthesia, and to alleviate systemic inflammatory response.
Considering the morbidity and mortality after surgery is closely related to use of anesthetics and inflammatory response,TEAS may be a good selection for improving postoperative outcomes.Among the postoperative complications, pulmonary complication and systemic inflammatory response syndrome is with higher incidence, so we will focus on these two complications in our study.
Study Type
Interventional
Enrollment (Actual)
748
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shaanxi
-
Xi'an, Shaanxi, China, 710032
- Xijing Hospital,Fourth Military Medical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Provide written informed consent
- Age ≥65 years of age
- Elective digestive surgery under general anesthesia
Exclusion Criteria:
- ASA(American Society of Anesthesiologists) status> Ⅲ
- Patients undergoing surgery within 12 h of admission to hospital
- Patients undergoing surgery of the chest
- Patients suffered from neurologic disorder or impaired mental state
- Patients with contraindications to the use of electro-acupuncture, such as skin damage or infection at the acupoints
- Patients with experience of transcutaneous electrical stimulation treatment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
Electrodes will be attached, but stimulation will not be given
|
|
|
Sham Comparator: Non-acupoint TES
TES is for transcutaneous electric stimulation.Stimulation will be given through electrodes attached to non-acupoints
|
Stimulation will be given through electrodes attached to the skin
|
|
Experimental: Acupoint TES
Transcutaneous stimulation will be given through acupoints
|
Stimulation will be given through electrodes attached to the skin
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of Participants with Pulmonary Adverse Events as a Measure of Morbidity Tolerability
Time Frame: participants will be followed from the end of the surgery to 30 days after surgery
|
participants will be followed from the end of the surgery to 30 days after surgery
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of participants died of all causes
Time Frame: Participants will be followed from the end of the surgery to 30 days after surgery
|
Participants will be followed from the end of the surgery to 30 days after surgery
|
|
Length of ICU stay
Time Frame: participants will be followed for the duration of hospital stay after surgery, an expected average of 7 days
|
participants will be followed for the duration of hospital stay after surgery, an expected average of 7 days
|
|
Number of participants with ICU admission
Time Frame: participants will be followed for the duration of hospital stay after surgery, an expected average of 7 days
|
participants will be followed for the duration of hospital stay after surgery, an expected average of 7 days
|
|
Number of participants with Systemic Inflammatory Response Syndrome(SIRS)
Time Frame: Participants will be followed from the end of the surgery to 30 days after surgery
|
Participants will be followed from the end of the surgery to 30 days after surgery
|
|
Length of hospital stay
Time Frame: participants will be followed for the duration of hospital stay after surgery, an expected average of 7days
|
participants will be followed for the duration of hospital stay after surgery, an expected average of 7days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Lize Xiong, PhD, Air Force Military Medical University, China
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2014
Primary Completion (Actual)
June 1, 2016
Study Completion (Actual)
October 1, 2016
Study Registration Dates
First Submitted
April 6, 2014
First Submitted That Met QC Criteria
September 10, 2014
First Posted (Estimate)
September 12, 2014
Study Record Updates
Last Update Posted (Actual)
July 7, 2017
Last Update Submitted That Met QC Criteria
July 6, 2017
Last Verified
July 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- XJH-A-2014-02-21-1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.